CD30 + Lymphoproliferative Disorders of the Skin

CD30+ lymphoproliferative disorders.

27. Thol F, Weissinger EM, Krauter J, Wagner K, Damm F, Wichmann F, et al. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 2010;95(10):1668-74. 28. Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and M...

Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders

It is critical to distinguish CD30+ T-cell LPDs from other CD30+ processes involving the skin that include: Systemic lymphomas (eg, systemic ALCL, ATLL, PTCL), Other cutaneous process such as other CD30+ skin lymphomas such as mycosis fungoides (MF), especially transformed MF, cytotoxic T-cell lymphomas, and Benign disorders such as lymphomatoid drug reactions, arthropod bites, viral infections...

Single-Fraction Radiotherapy for CD30+ Lymphoproliferative Disorders

OBJECTIVES CD30(+) lymphoproliferative disorder is a rare variant of cutaneous T-cell lymphoma. Sustained complete response following first-line treatments is rare. This retrospective review evaluates the response of refractory or recurrent lesions to palliative radiation therapy. METHODS The records of 6 patients with 12 lesions, treated with radiation therapy, were reviewed. All patients re...

Presence of t(2;5) in primary CD30+ cutaneous lymphoproliferative disorders.

Lymphomatoid plaquosis - a CD30+ lymphoproliferative rash exhibiting a predilection for recurrence on the same skin sites.

Aberrations in cutaneous T-cell immunology may result in rashes that recur at the same or similar sites in the skin, and include fixed drug eruption, psoriasis and mycosis fungoides (MF). Here we describe a patient with an unusual presentation of a cutaneous CD30 + lymphoproliferative disorder, manifesting as a rash with a tendency to repeatedly appear at the same skin locations before spontane...